BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jia HY, Ding F, Chen JY, Lian JS, Zhang YM, Zeng LY, Xiang DR, Yu L, Hu JH, Yu GD, Cai H, Lu YF, Zheng L, Li LJ, Yang YD. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. World J Gastroenterol 2015; 21(12): 3657-3662 [PMID: 25834334 DOI: 10.3748/wjg.v21.i12.3657]
URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3657.htm
Number Citing Articles
1
Ryo Koda, Masafumi Tsuchida, Noriaki Iino, Ichiei Narita. Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D DeficiencyInternal Medicine 2019; 58(6): 821 doi: 10.2169/internalmedicine.1698-18
2
Junko Takagi, Hiroyuki Morita, Kiyoaki Ito, Tomohiko Ohashi, Sho Hirase, Tatsuo Ito, Takkan Morishima, Kazuo Otake, Masashi Yoneda. Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus InfectionInternal Medicine 2016; 55(12): 1599 doi: 10.2169/internalmedicine.55.6301
3
Qing Luo, Yong Deng, Feifei Cheng, Juan Kang, Shan Zhong, Dazhi Zhang, Weiqiong Zeng. Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis BMedicine 2016; 95(50): e5578 doi: 10.1097/MD.0000000000005578
4
Ziyue Li, Chuan Shen, Yadong Wang, Wei Wang, Qian Zhao, Zhenzhong Liu, Yang Wang, Caiyan Zhao. Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis BMedicine 2016; 95(44): e5264 doi: 10.1097/MD.0000000000005264
5
Linli Sun, Dan Yi, Wei Sun, Chunjiang Wang. Retrospective analysis of the clinical characteristics of adefovir dipivoxil–induced Fanconi’s syndrome in the Chinese populationJournal of Clinical Pharmacy and Therapeutics 2020; 45(4): 722 doi: 10.1111/jcpt.13154
6
Jose A. Patricio, Patricia F. Lopes, Thalia Medeiros, Guilherme F. Mendes, Andrea A. Silva, Eliane B. Esberard, Jocemir R. Lugon, Jorge R. Almeida. Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin DEuropean Journal of Gastroenterology & Hepatology 2016; 28(1): 64 doi: 10.1097/MEG.0000000000000509
7
Xiaolu Wu, Shaohang Cai, Zhandong Li, Caixia Zheng, Xiulan Xue, Jianyong Zeng, Jie Peng. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysisVirology Journal 2016; 13(1) doi: 10.1186/s12985-016-0522-6
8
Qian Xiang, Zhiyan Liu, Yanyan Yu, Hanxu Zhang, Qiufen Xie, Guangyan Mu, Jianhua Zhang, Xinan Cen, Yimin Cui. Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case reportBMC Pharmacology and Toxicology 2020; 21(1) doi: 10.1186/s40360-020-00421-6
9
I. Carey, R. Byrne, K. Childs, M. Horner, M. Bruce, B. Wang, G. Dusheiko, K. Agarwal. Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis BJournal of Viral Hepatitis 2018; 25(10): 1139 doi: 10.1111/jvh.12916
10
Nan Chen, Jian-bo Zhang, Qiujie Zhang, Yun-peng Zhao, Li-yan Li, Li-wei Liu, Fei Yu, Xin Yu, Tao Peng, Kuan-xiao Tang. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case seriesBMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0212-7
11
Kaixin Song, Qi Yan, Yi Yang, Mengyue Lv, Yuting Chen, Yue Dai, Le Zhang, Yi Huang, Cuntai Zhang, Hongyu Gao. Fanconi syndrome induced by adefovir dipivoxil: a case report and clinical reviewJournal of International Medical Research 2020; 48(10): 030006052095471 doi: 10.1177/0300060520954713